B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging
Observational Model: Case Control, Time Perspective: Cross-Sectional
expression of cell surface antigens HLA-DR and CD38+ markers in B-CLL cells compared to normal B-lymphocytes
samples will be taken at the beginning, week 2, 4,6,8,12,and 24 (for blood), and bone marrow samples at weeks 2 and 6.
Nicholas Chiorazzi, MD
North Shore-LIJ Health System
United States: Federal Government
|Feinstein Institute for Medical Research||Manhassett, New York 11030|